4-Oxo-3,5-dihydro-4H-pyridazino[4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy
申请人:Sanofi-Synthelabo
公开号:US06262045B1
公开(公告)日:2001-07-17
Compounds of general formula (I)
in which X represents a hydrogen or halogen atom or a methyl, methoxy or phenylmethoxy group, Y represents a hydrogen atom, 1 or 2 halogen atoms or a hydroxyl, methoxy, nitro or methyl group, R1 represents a hydrogen atom or a (C1-C4)alkyl group, R2 and R3 each represent a hydrogen atom, a (C1-C4)alkyl group or a phenylmethyl group or else R2 and R3 form, with the nitrogen atom which carries them, an azetidinyl, pyrrolidinyl, 3-ethoxypyrrolidinyl, piperidinyl, morpholinyl, 4-methylpiperazinyl or 1,3-thiazolidinyl group. Application in therapeutics.
通式(I)的化合物中,X代表氢或卤素原子,或甲基,甲氧基或苯甲氧基基团,Y代表氢原子,1或2个卤素原子或羟基,甲氧基,硝基或甲基基团,R1代表氢原子或(C1-C4)烷基,R2和R3各代表氢原子,(C1-C4)烷基或苯甲基基团,或者R2和R3与它们所携带的氮原子形成氮杂环,包括氮杂丙环,吡咯烷环,3-乙氧基吡咯烷环,哌啶环,吗啉环,4-甲基哌嗪环或1,3-噻唑烷环。在治疗学中的应用。